Ledger.Open graph →
SEC Form D · filed March 25, 2021

Lennham Pharmaceuticals, Inc

Offering
$2.3M
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Concord, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Corey D. Macgregor · Concord, MAExecBenjamin D. Enerson · Concord, MAExecBradford C. Sippy · Concord, MAExec · DirectorMatthew Mcgraw · San Francisco, CAExecJames Boettcher · San Francisco, CAExecThomas Kuegler · Gulf Breeze, FLExec · DirectorPaul S. Bertrand · Drexel, MOExecKathleen A. Ruegsegger · Drexel, MOExecEric Varma · Greenwich, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗